Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

bluebird bio Inc (NASDAQ:BLUE)

92.65
Delayed Data
As of Aug 21
 +0.20 / +0.22%
Today’s Change
37.05
Today|||52-Week Range
123.75
+50.16%
Year-to-Date
No recent news for bluebird bio Inc.

Today’s Trading

Previous close92.45
Today’s open92.60
Day’s range91.15 - 93.50
Volume470,884
Average volume (3 months)882,260
Market cap$4.2B
Dividend yield--
Data as of 4:00pm ET, 08/21/2017

Growth & Valuation

Earnings growth (last year)-46.99%
Earnings growth (this year)+3.75%
Earnings growth (next 5 years)-31.83%
Revenue growth (last year)-56.28%
P/E ratioNM
Price/Sales373.75
Price/Book4.33

Competitors

 Today’s
change
Today’s
% change
TECHBio-Techne Corp+0.59+0.50%
EXASExact Sciences Corp+0.82+2.17%
NBIXNeurocrine Bioscienc...-0.02-0.04%
AVXSAveXis Inc+0.80+0.86%
Data as of 4:00pm ET, 08/21/2017

Financials

Next reporting dateNovember 16, 2017
EPS forecast (this quarter)-$1.69
Annual revenue (last year)$6.2M
Annual profit (last year)-$263.5M
Net profit margin-4,281.19%

Profile

Sector
Health Technology
Industry
Biotechnology
President &
Chief Executive Officer
Nick Leschly
Chief Operating Officer
Susanna G. High
Corporate headquarters
Cambridge, Massachusetts

Forecasts